Status:
UNKNOWN
Improving the Accuracy of Referrals of Patients With Chest Pain
Lead Sponsor:
VieCuri Medical Centre
Collaborating Sponsors:
Siemens Healthineers Nederland B.V.
Conditions:
Chest Pain
Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a multicenter, prospective, investigator-initiated, randomized controlled trial aiming to reduce the percentage of non-cardiac chest pain (NCCP) patients admitted to the cardiac emergency depa...
Detailed Description
Patients with acute coronary syndrome (ACS) should be referred to the hospital promptly. However, referring all patients with chest pain is not feasible, as recent studies showed that up to 80% of the...
Eligibility Criteria
Inclusion
- Age ≥ 18 years.
- Chest pain or other complaints suspect of ACS for at least 2 hours where the GP or emergency medical personnel are in need of further diagnostics or risk stratification to come to a decision of referral.
- Patients, who have been informed of the nature of the study, agree to its provisions and have provided written informed consent.
Exclusion
- Electrocardiographic ST-segment elevation/High suspicion of STE-ACS.
- Suspicion of an acute non-coronary diagnosis e.g. pulmonary embolism, thoracic aortic dissection or other life-threatening disease.
- Patients presenting cardiogenic shock, defined as: systolic blood pressure \<90mmHg and heart rate \>100 and peripheral oxygen saturation \<90% (without oxygen administration)
- Patients presenting with sudden onset heart rhythm disorders and second or third degree atrioventricular block.
- Patients with confirmed ACS, PCI or CABG \<30 days prior to inclusion.
- Impaired consciousness defined as an EMV \<8.
- Severe shortness of breath.
- Patients with known end-stage renal disease (dialysis and/or MDRD \< 30 ml/min).
- Patients with known cognitive impairment.
- Communication issues with patient/language barrier.
- Patients already participating in an interventional cardiology or cardiovascular trial.
Key Trial Info
Start Date :
July 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
852 Patients enrolled
Trial Details
Trial ID
NCT04904107
Start Date
July 4 2021
End Date
June 1 2024
Last Update
June 10 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Laurentius Hospital Roermond
Roermond, Limburg, Netherlands, 6043 CV
2
Viecuri Medical Centre Northern Limburg
Venlo, Limburg, Netherlands, 5912 BL